The maximum daily dose is 200 mg in a 24 hour period.If the migraine returns following an initial treatment with Sumatriptan injection, additional single Sumatriptan tablets (up to 100 mg/day) may be given with an interval of at least 2 hours between tablet doses.The safety of treating an average of more than 4 headaches in a 30 day period has not been established.If treatment is deemed advisable in the presence of mild to moderate hepatic impairment, the maximum single dose should not exceed 50 mg Sumatriptan tablets are contraindicated in patients with:The use of Sumatriptan tablets is contraindicated in patients with ischemic or vasospastic CAD. There was no evidence in either species of an increase in tumors related to Sumatriptan administration. Call your doctor for medical advice about side effects. All rights reserved. Drug interactions are reported among people who take Warfarin sodium and Sumatriptan together. These trials did not establish the efficacy of oral Sumatriptan compared with placebo in the treatment of migraine in adolescents. These drugs help treat dizziness, motion sickness, nausea and vomiting, and other symptoms.If you frequently experience episodes, your doctor may prescribe the same drugs that help prevent other kinds of migraines. Drugs.com provides accurate and independent information on more than 24,000 prescription drugs, over-the-counter medicines and natural products. Select one or more newsletters to continue. In general, anaphylactic reactions to drugs are more likely to occur in individuals with a history of sensitivity to multiple allergens. You may also experience symptoms including:Doctors aren’t certain what causes vestibular migraines, but some believe that the abnormal release of chemicals in the brain plays a role.Some of the same factors that triggers other kinds of migraines can trigger a vestibular migraine, including:Certain foods and drinks can also trigger a vestibular migraine:Women are at a greater risk for getting vestibular migraines. If you would like more information, talk with your healthcare provider. There are also reports in patients where no such predisposing factors are apparent. Sumatriptan often relieves other symptoms that occur together with a migraine headache, such as nausea, vomiting, sensitivity to light, and sensitivity to sound. This compares with a CProtein binding, determined by equilibrium dialysis over the concentration range of 10 to 1,000 ng/mL is low, approximately 14% to 21%. NDC 42043-222-09Store at 20° to 25°C (68° and 77°F). Additional medications were allowed 4 to 24 hours after the initial treatment for recurrent headache or as rescue in all 3 trials. All rights reserved.

These reports include reactions similar in nature to those reported rarely in adults, including stroke, visual loss, and death. If a patient has no response to the first migraine attack treated with Sumatriptan, reconsider the diagnosis of migraine before Sumatriptan is administered to treat any subsequent attacks. [see USP Controlled Room Temperature].Advise the patient to read the FDA-approved patient labeling (Patient Information).Inform patients that Sumatriptan tablets may cause serious cardiovascular side effects such as myocardial infarction or stroke. Patients were instructed to treat a moderate to severe headache. Make sure laboratory personnel and all your doctors know you use this drug.If someone has overdosed and has serious symptoms such as passing out or If you miss a dose, take it as soon as you remember. Take your next dose at the regular time.

This material is provided for educational purposes only and is not intended for medical advice, diagnosis or treatment.

NDC 42043-220-09Sumatriptan Tablets USP, 50 mg are pink colored, film coated, triangular biconvex debossed with “S” on one side and “103” on the other side, supplied in Unit dose packs -Carton of 9 Unit-dose tablets (1 x 9s) each with cross perforation and individually labeled. They may harm them.This Patient Information leaflet summarizes the most important information about Sumatriptan tablets.

Data sources include IBM Watson Micromedex (updated 2 Sep 2020), Cerner Multum™ (updated 1 … Pull the affected tooth. Additional smaller observational studies evaluating use of Sumatriptan during pregnancy have not suggested an increased risk of teratogenicity.Oral administration of Sumatriptan to rats prior to and throughout gestation resulted in embryofetal toxicity (decreased body weight, decreased ossification, increased incidence of skeletal abnormalities).